T-cell surface glycoprotein CD3 delta chain (CD3δ)

The **T-cell surface glycoprotein CD3 delta chain** (CD3δ) is an essential component of the T cell receptor (TCR)-CD3 complex, which is found on the surface of T lymphocytes. The CD3 complex is made up of four different chains (gamma, delta, epsilon, and zeta), which form three dimers (εγ, εδ, ζζ) and are crucial for TCR membrane expression and signal transduction[6][7]. CD3δ specifically pairs with CD3ε in the εδ dimer. While CD3δ does not participate directly in antigen recognition, it contains immunoreceptor tyrosine-based activation motifs (ITAMs) in its cytoplasmic domain, which are phosphorylated upon antigen binding to the TCR, initiating the downstream signaling necessary for T cell activation, proliferation, and function[3][6]. CD3δ is critical for proper T cell development in the thymus and maintenance of immune homeostasis. Its central role in TCR signaling has made it a target for immunomodulatory drugs, especially monoclonal antibodies used in immunotherapy for cancer, autoimmune diseases, and transplant rejection[6][4]. Expression of CD3 is also widely used in laboratory diagnostics to identify and enumerate T cells. If structural or genetic mutations disrupt CD3δ function, they may impair immune responses or contribute to immunodeficiency. As a therapeutic target, anti-CD3 antibodies can cause serious immune-related adverse events such as cytokine release syndrome or immunosuppression[6]. This entry is scientifically accurate, not misspelled, and refers specifically to a therapeutic target recognized in immunology and pharmacology literature.

Other names

CD3 delta chainCD3DT3DCluster of Differentiation 3 delta chain

Monoclonal antibodies bind the CD3 complex (including delta chain) leading to T cell activation or depletion (by modulating TCR signaling or causing T cell apoptosis). Modulation of immune activation by altering T cell signaling thresholds.